Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1976 Oct;4(4):349–353. doi: 10.1128/jcm.4.4.349-353.1976

Evaluation of commercial Salmonella O polyvalent and Vi antisera.

G M Evins, L L Linne, H M Colvin
PMCID: PMC274471  PMID: 977734

Abstract

Salmonella somatic polyvalent antisera for groups A through E or A through I with or without Vi and Salmonella Vi antisera were purchased from four commercial producers and evaluated. Center for Disease Control (CDC) methods and specifications were used. The four polyvalent and two of the four Vi antisera did not meet CDC performance specifications. Suggestions are made for improving the laboratory usefulness of the reagents and the product labeling.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Le Minor L., Rohde R., Charié-Marsaines C., Coynault C. Etude sur les rapports antigéniques entre le groupe O:54 et d'autres groupes O de Salmonella. Ann Inst Pasteur (Paris) 1971 Oct;121(4):447–463. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES